7.49 USD
▼-0.08-1.06%
盘后 7.54 +0.67%
2026-09-15
市值
$1.42B
市盈率
126.52
EPS
-0.10
股息率
—
52 周区间
5.25 – 10.08
成交量
1.18M
Beta
0.85
目标价
12.29
52W 低 5.2552W 高 10.08
价格走势
公司简介
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patient...